A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Taking an Antihistamine (Zyrtecֲ®) or Placebo Prior to Daily Injections of Copaxoneֲ®.
Teva Identifier
PM014
ClinicalTrials.gov Identifier
NCT00240032
Study Status
Completed
Trial Condition(s)
Multiple Sclerosis
Interventions
Drug: glatiramer acetate injection with oral cetirizine hydrochloride | Drug: glatiramer acetate with placebo
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
You are about to leave the Teva Pharmaceuticals global website
The website you are about to access may be governed by different regional policies, regulations or advertising codes. Please be sure to read the privacy policy and terms of use of the websites that you visit.
Teva Pharmaceuticals is not responsible for the accuracy or compliance with laws of information on any third party websites.